AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (April 13, 2006). doi:10.1152/ajpgi.00557.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/G414    most recent
00557.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plosch, T.
Right arrow Articles by Kuipers, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plosch, T.
Right arrow Articles by Kuipers, F.
Submitted on December 9, 2005
Accepted on April 9, 2006

Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice

Torsten Plosch1*, Jelske N. van der Veen1, Rick Havinga1, Nicolette C.A. Huijkman1, Vincent W. Bloks1, and Folkert Kuipers2

1 Center for Liver, Digestive and Metabolic Diseases, Laboratory of Pediatrics, University Medical Center Groningen, Groningen, Netherlands
2 Laboratory of Pediatrics, University Medical Center Groningen, Center for Liver, Digestive and Metabolic Disease, 9713 EZ Groningen, United States

* To whom correspondence should be addressed. E-mail: t.ploesch{at}med.umcg.nl.

The ABC half-transporters ABCG5 and ABCG8 heterodimerize into a functional complex that mediates hepatobiliary sterol secretion. We have addressed the putative rate-controlling role of Abcg5/Abcg8 in mice during stimulation of this process. Despite similar bile salt (BS) excretion rates, basal total sterol and phospholipid (PL) output was reduced by 82 % and 35 %, respectively, in Abcg5-/- mice. Upon infusion with the hydrophilic bile salt TUDCA, similar relative increases in bile flow, BS output, PL output and total sterol output were observed in wild-type, Abcg5+/- and Abcg5-/- mice. Maximal cholesterol and PL output rates in Abcg5-/- mice were only 15 % and 69 %, respectively, of wild-type values. Infusion of increasing amounts of the hydrophobic bile salt TDCA increased cholesterol excretion 3.0- and 2.4-fold in wild-type and Abcg5-/- mice, but rapidly induced cholestasis in Abcg5-/- mice. Treatment with the LXR agonist T0901317 increased the maximal sterol excretion capacity in wild-type mice (4-fold), concomitant with induction of Abcg5/Abcg8 expression, but not in Abcg5-/- mice. In a separate study, mice were fed chow containing 1% cholesterol. As expected, hepatic expression of Abcg5/Abcg8 was strongly induced (4-fold) in wild-type but not in liver x-receptor alpha-deficient (Lxra-/-) mice. Surprisingly, hepatobiliary cholesterol excretion was increased to the same extent, i.e., 2.2-fold in wild-type and 2.0-fold in Lxra-/- mice, upon cholesterol-feeding. Our data confirm that Abcg5, as part of the Abcg5/Abcg8 heterodimer, strongly controls hepatobiliary cholesterol secretion in mice. However, we demonstrate that Abcg5/Abcg8-independent, inducible routes exist that can significantly contribute to total hepatobiliary cholesterol output.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.